litlas
Log inCreate account

Philip Raskin

Active 1972–2025

92
Papers
19,212
Citations
76
h-index
91
i10-index

Citations

Citations per year for Philip Raskin1975: 1 citations1977: 2 citations1978: 5 citations1979: 4 citations1980: 12 citations1981: 14 citations1982: 11 citations1983: 5 citations1984: 11 citations1985: 12 citations1986: 21 citations1987: 21 citations1988: 15 citations1989: 14 citations1990: 20 citations1991: 14 citations1992: 20 citations1993: 8 citations1994: 17 citations1995: 15 citations1996: 17 citations1997: 16 citations1998: 15 citations1999: 27 citations2000: 36 citations2001: 51 citations2002: 74 citations2003: 75 citations2004: 72 citations2005: 99 citations2006: 103 citations2007: 109 citations2008: 124 citations2009: 129 citations2010: 144 citations2011: 160 citations2012: 205 citations2013: 206 citations2014: 177 citations2015: 190 citations2016: 142 citations2017: 135 citations2018: 123 citations2019: 376 citations2020: 436 citations2021: 359 citations2022: 304 citations2023: 318 citations2024: 440 citations2025: 247 citations2026: 11 citations1976: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,913 citing papers, 28.6% of this breakdownUnited Kingdom: 554 citing papers, 8.3% of this breakdownChina: 403 citing papers, 6% of this breakdownItaly: 334 citing papers, 5% of this breakdownGermany: 307 citing papers, 4.6% of this breakdownCanada: 272 citing papers, 4.1% of this breakdownAustralia: 221 citing papers, 3.3% of this breakdownDenmark: 206 citing papers, 3.1% of this breakdownNetherlands: 191 citing papers, 2.8% of this breakdownFrance: 186 citing papers, 2.8% of this breakdownJapan: 184 citing papers, 2.7% of this breakdownSpain: 163 citing papers, 2.4% of this breakdown
0%28.6%Other 26.3%

Institutions

Fields

  • Medicine66.3%
  • Biochemistry, Genetics and Molecular Biology26.1%
  • Immunology and Microbiology2.5%
  • Nursing1.2%
  • Engineering1%
  • Neuroscience0.8%
  • Other2.1%

Topics

  • Diabetes Management and Research7.4%
  • Diabetes Treatment and Management6.5%
  • Diabetes and associated disorders6%
  • Pancreatic function and diabetes6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.9%
  • Metabolism, Diabetes, and Cancer2.4%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Vitamin D Supplementation and Prevention of Type 2 Diabetes

    Authors: Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan, James H. Ware, William C. Knowler, Vanita R. Aroda, Irwin Brodsky, Lisa Ceglia, Chhavi Chadha, Ranee Chatterjee, Cyrus Desouza, Rowena J Dolor, John P. Foreyt, Paul Fuss, Adline Ghazi, Daniel S. Hsia, Karen Johnson, Sangeeta R. Kashyap, Sun H. Kim, Erin S. LeBlanc, Michael R. Lewis, Emilia Liao, Lisa M. Neff, Jason Nelson, Patrick M. O’Neil, Jean Park, Anne L. Peters, Lawrence S. Phillips, Richard E. Pratley, Philip Raskin, Neda Rasouli, David C. Robbins, Clifford J. Rosen, Ellen M. Vickery, Myrlene A. Staten - New England Journal of Medicine 2019 cited by 664

  2. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler - New England Journal of Medicine 2009 cited by 1,073

  3. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    Authors: Pablo E. Pérgola, Philip Raskin, Robert D. Toto, Colin J. Meyer, Jesse W. Huff, Eric Grossman, Melissa Krauth, Stacey Ruiz, Paul Audhya, Heidi Christ‐Schmidt, Janet Wittes, David G. Warnock - New England Journal of Medicine 2011 cited by 876

  4. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Authors: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 cited by 601

  5. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

    Authors: William E. Russell, Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Michael J. Haller, Jeffrey P. Krischer, Ingrid Libman, Peter S. Linsley, S. Alice Long, Sandra Lord, Daniel J. Moore, Wayne V. Moore, Antoinette Moran, Andrew Muir, Philip Raskin, Jay S. Skyler, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, Anette‐Gabriele Ziegler, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 cited by 96

  6. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Authors: Mark Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, the Immune Tolerance Network (ITN) T1DAL Study Group - Journal of Clinical Investigation 2015 cited by 292

  7. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    Authors: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco and 212 more - Diabetes Care 2018 cited by 180

  8. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, Noha Lim, Lori Blanchfield, Linda A. DiMeglio, Eric I. Felner, Jason L. Gaglia, Peter A. Gottlieb, S. Alice Long, Andrea Mari, Raghavendra G. Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M. Wentworth, Steven M. Willi, Jeffrey P. Krischer, Jeffrey A. Bluestone, Mayalin Barr, Lori Blanchfield, Jeffrey A. Bluestone, Jeanne Buchanan, Brian N. Bundy, Joanne Cabbage, Peter G. Coleman, Monica De La Vega, Linda A. DiMeglio, Carmella Evans‐Molina, Eric I. Felner, Ele Ferrannini, Christine Ferrara, Jason L. Gaglia, Stephen E. Gitelman, Peter A. Gottlieb, Felicity Healy, Laurie Higgins, Megan Hildinger, Margaret A. Jenkins, Nora Bryant, Amanda Kinderman, Nisha Koshy, Brianne Kost, Jeffrey P. Krischer, Suzanne Krishfield, Olena Kucheruk, Noha Lim, Karen L. Lindsley, S. Alice Long, Manasa Mantravadi, Andrea Mari, Shelley Mesfin, Aaron W. Michels, Mary Ellen Migre, Pantea Minnock, Raghavendra G. Mirmira, Elham Mohammed-Nur, Jennifer B. Nelson, Ashvin Nursing, Ryan O’Donnell, Diana R. Olivos, Melissa M. Parker, Philip Raskin, Leanne Redl, Nicole Reed, Brittany Resnick, Srinath Sanda, Peter H. Sayre, Elisavet Serti, Emily Sims, Karen Smith, Carol L. Soppe, Fiona Stuart, Sarah Szubowicz, Michel Tansey, Jennifer Terrell, Sarah A. Tersey, Christine Torok, Eva Tsalikian, Kelly Watson, John M. Wentworth, Rebecca Wesch, Steven M. Willi, Stéphanie Woerner - The Lancet Diabetes & Endocrinology 2021 cited by 133

  9. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Brian N. Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Anti-CD20 Study Group - Diabetes Care 2013 cited by 282

  10. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

    Authors: Antoinette Moran, Brian N. Bundy, Dorothy Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, Srinath Sanda, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, Linda Pickersgill, Eelco J.P. de Koning, Anette‐G. Ziegler, Bernhard O. Boehm, Klaus Badenhoop, Nanette C. Schloot, J. F. Bak, Paolo Pozzilli, Dı́dac Mauricio, Marc Y. Donath, Luís Castaño, Ana M. Wägner, H. H. Lervang, Hans Perrild, Thomas Mandrup‐Poulsen - The Lancet 2013 cited by 354

  11. Cardiac Steatosis in Diabetes Mellitus

    Authors: Jonathan McGavock, Ildiko Lingvay, Ivana Zib, Tommy Tillery, Naomi Salas, Roger H. Unger, Benjamin D. Levine, Philip Raskin, Ronald G. Victor, Lidia S. Szczepaniak - Circulation 2007 cited by 607

  12. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

    Authors: Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan Warnock, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jane H. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter Gottlieb, Kevan C. Herold, Mikael Knip, Jeffrey P. Krischer, Åke Lernmark, Wayne D. Moore, Antoinette Moran, Andrew J. Muir, Jerry P. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, William E. Russell, Desmond A. Schatz, Jay M. Sosenko, Lisa M. Spain, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette G. Ziegler, Mark S. Anderson, Peter A. Antinozzi, Richard A. Insel, Thomas W. H. Kay, Jennifer B. Marks, Alberto Pugliese, Bart O. Roep, Jay S. Skyler, Jorma Toppari, Carla J. Greenbaum, Jeffrey P. Krischer, Ellen Leschek, Lisa Spain, Katarzyna Bourcier, Richard A. Insel, J P Ridge, Jay S. Skyler, Carla J. Greenbaum, Lisa Rafkin, Jay M. Sosenko, Jay S. Skyler, Irene Santiago, Jeffrey P. Krischer, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Ilma Asif, Jenna Bjellquist, Matthew Boonstra, Cristina Burroughs, Mario Cleves, David Cuthbertson, Meagan DeSalvatore, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson, Susan Geyer and 178 more - Diabetes 2019 cited by 131

  13. Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

    Authors: Bernard Zinman, John Gerich, John B. Buse, Andrew Lewin, Sherwyn Schwartz, Philip Raskin, Paula M. Hale, Milan Zdravkovic, Lawrence Blonde, the LEAD-4 Study Investigators - Diabetes Care 2009 cited by 838

  14. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Authors: Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Tihamer Orban, Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 cited by 369

  15. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

    Authors: Mark Rigby, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Chetanbabu M Patel, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Antoinette Moran, William E. Russell, Ashley Pinckney, Lynette Keyes-Elstein, Michael Howell, Sudeepta Aggarwal, Noha Lim, Deborah Phippard, Gerald T. Nepom, James McNamara, Mario R. Ehlers - The Lancet Diabetes & Endocrinology 2013 cited by 206

  16. Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

    Authors: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Mark Peakman, Philip Raskin, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Abatacept Study Group - Diabetes Care 2013 cited by 204

  17. Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

    Authors: Uzma F. Mehdi, Beverley Adams‐Huet, Philip Raskin, Gloria Lena Vega, Robert D. Toto - Journal of the American Society of Nephrology 2009 cited by 386

  18. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

    Authors: Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team - JCI Insight 2021 cited by 58

  19. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

    Authors: George L. Bakris, Vivian Fonseca, Richard E. Katholi, Janet B. McGill, Franz H. Messerli, Robert A. Phillips, Philip Raskin, Jackson T. Wright, Rosemary Oakes, Mary Ann Lukas, Karen M. Anderson, David S.H. Bell, for the GEMINI Investigators - JAMA 2004 cited by 792

  20. Hyperglycemia and Acute Coronary Syndrome

    Authors: Prakash Deedwania, Mikhail Kosiborod, Eugene J. Barrett, Antonio Ceriello, William L. Isley, Theodore Mazzone, Philip Raskin - Circulation 2008 cited by 495

  21. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes

    Authors: Matthew J. Budoff, Jye‐Yu C. Backlund, David A. Bluemke, Joseph F. Polak, Ionut Bebu, David S. Schade, Suzanne Strowig, Philip Raskin, John M. Lachin - JACC. Cardiovascular imaging 2019 cited by 76

  22. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes

    Authors: Davida Kruger, Alex Kass, Jacqueline Y. Lonier, Jeremy Pettus, Philip Raskin, Maamoun Salam, Subbulaxmi Trikudanathan, Keren Zhou, Steven J. Russell, Edward R. Damiano, Firas H. El-Khatib, Katrina J. Ruedy, COURTNEY A. BALLIRO, Zoey Li, Martin Chase Marak, Peter Calhoun, Roy W. Beck - Diabetes Technology & Therapeutics 2022 cited by 36

  23. Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    Authors: W. Kline Bolton, Daniel C. Cattran, Mark E. Williams, Sharon G. Adler, Gerald B. Appel, Kenneth Cartwright, Peter G. Foiles, Barry I. Freedman, Philip Raskin, Robert E. Ratner, Bruce Spinowitz, Frederick C. Whittier, Jean-Paul Wuerth, f for the ACTION I Investigator Group - American Journal of Nephrology 2004 cited by 453

  24. Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes

    Authors: Neda Rasouli, Irwin Brodsky, Ranee Chatterjee, Sun H. Kim, Richard E. Pratley, Myrlene A. Staten, Anastassios G. Pittas, Anastassios G. Pittas, Irwin Brodsky, Lisa Ceglia, Chhavi Chadha, Ranee Chatterjee, Bess Dawson‐Hughes, Cyrus Desouza, Rowena J Dolor, John P. Foreyt, Adline Ghazi, Daniel S. Hsia, Karen Johnson, Sangeeta R. Kashyap, Sun H. Kim, Erin S. LeBlanc, Michael R. Lewis, Emilia Liao, Saúl Malozowski, Lisa M. Neff, Patrick M. O’Neil, Jean Park, Anne L. Peters, Lawrence S. Phillips, Richard E. Pratley, Philip Raskin, Neda Rasouli, David C. Robbins, Clifford J. Rosen, Dave Reboussin, Vanita R. Aroda, James H. Ware, Patricia Sheehan, Myrlene A. Staten, William C. Knowler - The Journal of Clinical Endocrinology & Metabolism 2021 cited by 61